Harlanw Waksal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harlanw waksal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harlanw Waksal Today - Breaking & Trending Today

Lyra Therapeutics Announces Closing of $50.0 Million

WATERTOWN, Mass., June 01, 2023 (GLOBE NEWSWIRE) Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology. ....

United States , Ellen Cavaleri , Maria Palasis , Harlanw Waksal , Hc Wainwright Co , Cantor Fitzgerald Co , William Blair Company , While The Company , Lyra Therapeutics Inc , Company Quarterly Report On Form , Perceptive Advisors , Venrock Healthcare Capital Partners , Armistice Capital , Surveyor Capital , North Bridge Venture Partners , Nantahala Capital , Samsara Biocapital , Woodline Partners , Chief Executive Officer , Executive Chairman , William Blair , Securities Act , Private Securities Litigation Reform Act , Quarterly Report , Investor Relations , Nasdaq Lyra ,

Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ Lyra Therapeutics, Inc. (NASDAQ: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,. ....

Kathryn Morris , Harlanw Waksal , Lyra Therapeutics Inc , Lyra Therapeutics , Award Plan , Executive Chairman , Nasdaq Listing Rule , Private Securities Litigation Reform Act , Quarterly Report ,

Lyra Therapeutics Announces Closing of $100.5 Million Private Placement

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,. ....

Kathryn Morris , Maria Palasis , Harlanw Waksal , Health Partners , Exchange Commission , Prnewswire Lyra Therapeutics Inc , Lyra Therapeutics Inc , Nantahala Capital Management , Venrock Healthcare Capital Partners , Samsara Biocapital , Perceptive Advisors , North Bridge Venture Partners , Pura Vida , Chief Executive Officer , Executive Chairman , Securities Act , Private Securities Litigation Reform Act , Annual Report , Lyra Therapeutics ,

Lyra Therapeutics closes $100.5M private placement - Drug Delivery Business

Lyra Therapeutics (Nasdaq:LYRA) announced today that it closed its previously announced private placement worth $100.5 million. ....

Harlanw Waksal , Nantahala Capital Management , Lyra Therapeutics , Therapeutics Executive Chair , Venrock Healthcare Capital Partners , Samsara Biocapital , Perceptive Advisors , North Bridge Venture Partners , Pura Vida Investments , Massachusetts Based Lyra Therapeutics ,

Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,. ....

United States , Appointedjim Tobin , Kathryn Morris , Maria Palasis , Harlanw Waksal , Boston Scientific Corporation , Company Board Of Directors , Baxter International , Biogen Inc , Meeting Of The American Rhinologic Society , Lyra Therapeutics Inc , Board At Transmedics Inc , Lyra Therapeutics , Chief Executive Officer , Combined Otolaryngology Spring Meetings , Fourth Quarter , Clinical Developments , Receive Top Clinical Award , Annual Meeting , American Rhinologic Society , Science Maurice Cottle Award , Month Post Treatment Data , Executive Chairman , Kadmon Holdings , Jim Tobin , Chief Operating Officer ,